Genome Study in Constitutional Thinness (GENOSCANN)

Constitutional thinness (CT) is a recently defined entity as a differential diagnosis of anorexia nervosa (AN), considered to be the most frequent cause of low body mass index (BMI) in young women. CT subjects present no AN psychiatric traits, preserved menses, no biological signs of undernutrition and balanced energy metabolism despite a Body Mass Index (BMI) <17 kg / m².

CT familial aggregation, low body mass without a hormonal explanation, and specific appetite regulation profile suggest a specific genetic profile in these subjects.

Objective: A family linkage study in order to identify genes involved in the constitutional thinness phenotype by using genome wide scan (GWAS) techniques Studied population: Fifty families including at least one well phenotyped CT index case (grade 2 or 3 of thinness according WHO classification). Blood or saliva is sampled for DNA extraction.

Perspectives: Revealing eventual abnormalities could lead to a more precise diagnosis of constitutional thinness and new hypothesis in understanding extreme bodyweight mechanisms.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

210

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Etienne, France, 42055
        • CHU SAINT-ETIENNE

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Fifty families including at least 2 well phenotyped CT index case (grade 2 or 3 of thinness according WHO classification) and members without CT.

Description

Inclusion Criteria:

  • For all subjects:

    • age > 18 yrs
    • affiliation to health insurance
    • member of a family including at least 2 CT members and overall 3 evaluable members over 2 generations
    • written and signed consent
  • For CT subjects :

    • grade 2 or 3 of thinness according WHO classification
    • women, BMI < 17 kg/m² at 20-30 yrs or < 19 for older subjects
    • men, BMI < 18 kg/m² at 20-30 yrs or < 20 for older subjects
    • absence of DSM criteria for anorexia nervosa
    • young women : normal menses and fat mass percentage 15 % ; absence of DSM criteria for anorexia nervosa
    • men : normal testosterone level
  • For subjects without CT :

    • women, BMI > 19 kg/m²
    • men, BMI > 20 kg/m²

Exclusion Criteria:

  • CT subjects:

    • smoking > 5 cigarettes / day
    • history of emaciating pathologies
    • intense physical activity > 7 hours / week
  • For all subjects :

    • refuse of written consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
CT subjects
blood or saliva specimen
blood or saliva specimen is sampled for DNA extraction in CT family's members
subjects without CT
blood or saliva specimen
blood or saliva specimen is sampled for DNA extraction in CT family's members

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
chromosome regions' abnormalities
Time Frame: day 1
The linkage study is performed in order to identify one or several chromosome regions linked the constitutional thinness phenotype by using genome wide scan (GWAS) techniques in CT families members.
day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
genetic markers
Time Frame: day 1
Identify within upper mentioned regions more specific genetic markers (mutation/variant) to characterize genes involved in CT phenotype
day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bruno Estour, MD PhD, CHU SAINT-ETIENNE
  • Principal Investigator: Bogdan GALUSCA, MD PhD, CHU SAINT-ETIENNE

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 21, 2010

Primary Completion (Actual)

November 11, 2019

Study Completion (Actual)

November 11, 2019

Study Registration Dates

First Submitted

August 13, 2015

First Submitted That Met QC Criteria

August 13, 2015

First Posted (Estimate)

August 17, 2015

Study Record Updates

Last Update Posted (Actual)

July 10, 2020

Last Update Submitted That Met QC Criteria

July 9, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0908129
  • 2010-A00051-38 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thinness

Clinical Trials on blood or saliva specimen

3
Subscribe